Magnetoencephalography in Children

Recruiting

• Conditions: Epilepsy; Autism; ADHD - Attention Deficit Disorder With Hyperactivity; Neuropsychiatric Disorders; Tic Disorder, Childhood; Intracranial Tumors; Cerebrovascular Disease; Mental Retardation; Developmental Disabilities

• Registration Number: NCT06668519
• Lead Sponsor: Children's Hospital of Fudan University

Brief Summary

This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.

Detailed Description

The purpose of this study is to observe the application of magnetoencephalography (MEG) in pediatric neurodevelopmental disorders

Study Timeline

• Study Start: 2024-09-25
• Study First Submitted: 2024-10-30
• Study First Submitted QC: 2024-10-30
• Study First Posted: 2024-10-31
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-11
• Last Update Posted: 2024-11-12
• Primary Completion: 2027-12-30
• Study Completion: 2027-12-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1500

Inclusion Criteria

1. aged 1 month-18 years old (date of investigate minus date of birth)
2. epilepsy
3. intracranial tumors
4. cerebrovascular diseases
5. autism
6. mental retardation
7. ADHD
8. tic disorder
9. neuropsychiatric disorders

Exclusion Criteria

1.Unable to cooperate with the exam of MEG

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children	3 years	Acquisition of magnetoencephalography (MEG) signals based on Inclusion Criteria

Trial Locations

Locations (1)

Children's Hospital of Fudan University; 🇨🇳 Shanghai, China